GE HealthCare Technologies GEHC AVS — D&A
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by GE HealthCare Technologies in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The official record: GE HealthCare Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about GE HealthCare Technologies's avs — d&a.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is GE HealthCare Technologies's AVS — D&A?
- GE HealthCare Technologies (GEHC) reported AVS — D&A of $18M in Q1 2026.
- How has GE HealthCare Technologies's AVS — D&A changed year-over-year?
- GE HealthCare Technologies's AVS — D&A decreased by 0.0% year-over-year, from $18M to $18M.
- What is the long-term trend for GE HealthCare Technologies's AVS — D&A?
- Over 3 years (2022 to 2025), GE HealthCare Technologies's AVS — D&A has grown at a -12.2% compound annual growth rate (CAGR), from $105M to $71M.
- What does AVS — D&A mean?
- The systematic allocation of the cost of tangible and intangible assets over their useful lives within the segment. This non-cash expense reflects the wear and tear or expiration of assets used to generate segment revenue.